Increasing rates of maternal opioid use during pregnancy and neonatal withdrawal, termed
neonatal abstinence syndrome (NAS), are public health concerns. Prenatal buprenorphine …

Neonates who have had in utero exposures from maternal substance abuse can experience
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …

Background: There are few data regarding the utilization of opioids during pregnancy. The
objective of this study was to define the prevalence and patterns of opioid use in a large …

Aim Neonatal abstinence syndrome (NAS) is an increasingly common disorder diagnosed in
infants exposed to various drugs, causing immense financial and social burden …

Maternal drug use and neonatal abstinence syndrome (NAS) are being seen across the
United States. NAS occurs with withdrawal disturbances in response to the cessation of the …

Exposure to prescription medications and illicit drug use during pregnancy has been
associated with neonatal abstinence syndrome. The clinical presentation consists of …

An evidence-based, multidisciplinary neonatal abstinence syndrome protocol was
developed using a stepwise continuous quality improvement (CQI) approach with the goal of …

Collaboration skills and proficiency in telehealth communication technologies are essential
competencies for all advanced practice nurses and are especially important for those in rural …

Opioid dependence has become an epidemic in the United States with more than tripling of
reported nonmedical use of prescripted narcotics and deaths between 1999 and 2010 (Fig …

We present the case of a 6-week-old male infant with Neonatal Abstinence Syndrome (NAS)
in which DonnatalTM (phenobarbital, hyoscyamine, atropine, hyoscine) Elixir was used as …